Teva expands marketing partnership on MS drug - Bioscience Technology
Posted Mon, 02/08/2010 - 14:13
Bioscience Technology By AP Monday, February 8, 2010 Teva Pharmaceutical Industries Ltd. said Monday it altered the terms of a partnership on a potential multiple sclerosis drug, ... Teva, Active extend pact on oral MS therapyMarketWatch Teva extends oral laquinimod marketing rightsGlobes Market Report -- In Play (TEVA)MSN Money PR-inside.com (press release) all 39 news articles » |
Other stories you might want to see…
- Israeli Teva gets rights for multiple sclerosis drug in Nordic, Baltic states - Trading Markets (press release)
- Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic ... - MarketWatch
- Israel stocks slip; Teva off before earnings report - MarketWatch
- Teva to launch Laquinimod lupus clinical trial - Globes
- Deutsche Bank: Buy Teva despite rival to Copaxone - Globes